HT
XENE icon

HAP Trading’s Xenon Pharmaceuticals XENE Stock Holding History

HAP Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$2.09K – 1110
2023
Q4 		$2.09K Buy
+20,000
New +$707K ﹤0.01% 848
2022
Q2 		– Sell
-20,000
Closed -$23K – 2412
2022
Q1 		$23K Sell
20,000
-1,200
-6% -$35.9K ﹤0.01% 1513
2021
Q4 		$82K Buy
21,200
+4,200
+25% +$126K ﹤0.01% 1297
2021
Q3 		$112K Buy
17,000
+4,900
+40% +$85.1K ﹤0.01% 1227
2021
Q2 		$91K Buy
+12,100
New +$223K ﹤0.01% 1250

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return